MS in the Media - 30 August 2019
24 - 30 August 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Possible causes of MS reviewed
Different factors affect onset, relapses and progression on MS according to a review of previous research. A combination of genetic susceptibility along with exposure to environmental factors (particularly before the age of 15) and covered - including vitamin D and sun exposure, infections, gender differences, smoking and obesity.
Source: Healthline
MS Trust link: Causes of MS
Lemtrada serious side effects review
Treatment with Lemtrada is currently restricted whilst a review of serious side effects is conducted. One of the studies that identified these issues was a Norwegian review of a database of adverse reactions linked to medication. This identified nine probable and one possible deaths in Europe linked to the drug between 2013 and 2018.
Source: MS News Today
MS Trust link: Lemtrada (alemtuzumab)
Exoskeleton helps people with MS walk
Early results from a UK study of robotic legs to help people with MS are positive. Reports include a father who was able to walk his daughter down the aisle and a man hoping to dance with his new wife when he marries next year.
Source: Kent Online
Source: Kent Online
MS Trust link: Walking difficulties
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
